Schizophrenia Patients clinical trials

Explore recruiting schizophrenia patients clinical trials.

Recruiting schizophrenia patients studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Schizophrenia Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

"A double blind, randomized, placebo-controlled, adaptive 24-week Phase II trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia" (EVOLUTION STUDY)

Spain, Bulgaria, Romania, Poland, Slovakia

Therapeutic exploratory (Phase II) EU CTIS Study details

An open label signal detection study to evaluate the effects of cariprazine on cognitive functioning in patients with schizophrenia in need of adjustment of oral antipsychotic treatment

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Schizophrenia Patients trials by city

Schizophrenia Patients in Toronto Schizophrenia Patients in Vancouver Schizophrenia Patients in Montreal Schizophrenia Patients in Calgary Schizophrenia Patients in Edmonton Schizophrenia Patients in Ottawa Schizophrenia Patients in Winnipeg Schizophrenia Patients in Quebec City Schizophrenia Patients in Hamilton Schizophrenia Patients in Kitchener Schizophrenia Patients in London Schizophrenia Patients in Halifax Schizophrenia Patients in New York Schizophrenia Patients in Los Angeles Schizophrenia Patients in Chicago Schizophrenia Patients in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease